J&J completes acquisition of Ci:z Holdings

Japan |  News | 0 Comment | 18 Jan, 2019

Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase price of approximately ¥230 billion. The acquisition was completed...Read more

AIVITA gets IND nod for Phase 1B melanoma trial

Japan |  News | 0 Comment | 17 Jan, 2019

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New ...Read more

Daiichi Sankyo to lead open innovation research on cell therapy

Japan |  News | 0 Comment | 11 Jan, 2019

Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Tokyo Institute of Technology have announced that they will commence open innovation research with the aim of creating ...Read more

Japan approves Amgen's osteoporosis drug

Japan |  News | 0 Comment | 10 Jan, 2019

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorization for EVENITY (romosozumab) for the treatment of osteoporosis in pa...Read more

Daiichi Sankyo receives regulatory approval for hypertension tablets

Japan |  News | 0 Comment | 10 Jan, 2019

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for esaxerenone tablets, MINN...Read more

NapaJen Pharma closes $12.4M Series C financing

Japan |  News | 0 Comment | 09 Jan, 2019

NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery technology to develop novel immunotherapeutic agents, has announced ...Read more

Takeda completes acquisition of Shire

Japan |  News | 0 Comment | 08 Jan, 2019

Takeda Pharmaceutical Company Limited (“Takeda”) announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven ...Read more

Fujifilm to invest 10B Yen in Bio CDMO biz

Japan |  News | 0 Comment | 08 Jan, 2019

FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in order to expand its Bio Contract Development and Manufacturing Organi...Read more

Solasia initiates Phase III programme for PledOx

Japan |  News | 0 Comment | 07 Jan, 2019

Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Solasia acquired exclusive development and commercialization rights for ...Read more

Otsuka, Click Therapeutics to create therapy for mental illness

Japan |  News | 0 Comment | 07 Jan, 2019

Otsuka Pharmaceutical Co., Ltd. announces that its U.S. holding company subsidiary Otsuka America, Inc, and Click Therapeutics, Inc. (Click) have signed a collaboration agreement for Otsuka...Read more

Takeda announces multiple cell therapy collaborations

Japan |  News | 0 Comment | 04 Jan, 2019

Takeda Pharmaceutical  has announced new research collaborations in immuno-oncology (I-O), an area of key strategic focus for the company. Through these collaborations, Takeda seeks to...Read more

Researchers discover laminin which can convert stem cells into retinal-like cells

Japan |  News | 0 Comment | 02 Jan, 2019

Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into various cell types in the human eye.  Growing the stem cells on a protein...Read more

MediPharm Labs declares its addition to HMMJ Index

Japan |  News | 0 Comment | 31 Dec, 2018

MediPharm Labs Corp., a specialized, research-driven cannabis extraction business licensed under the Cannabis Act, is pleased to announce its addition to the Horizons Marijuana Life Science...Read more

Taisho Pharmaceutical Holdings to purchase BMS's UPSA

Japan |  News | 0 Comment | 30 Dec, 2018

Bristol-Myers Squibb Company recently announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myers Squibb’s UPSA consumer health business for $1.6 billion. UPSA...Read more

Prevelance of colistin-resistance high in Vietnam: Research

Japan |  News | 0 Comment | 28 Dec, 2018

A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents of rural communities in Vietnam to find that the prevalence of colist...Read more

Chugai obtains approval for Genomic Mutation Analysis Program

Japan |  News | 0 Comment | 27 Dec, 2018

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for “FoundationOne® CDx Cancer Genomic Profi...Read more

Rakuten Aspyrian closes $284 Million Series C Financing for late-stage oncology pipeline

Japan |  News | 0 Comment | 26 Dec, 2018

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform has announced that it has raised an additional ...Read more

Mundipharma applies for marketing Remimazolam in Japan

Japan |  News | 0 Comment | 21 Dec, 2018

Mundipharma has submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimazolam for general anesthesia in Japan. Mundipharma prepared this submiss...Read more